CytomX Therapeutics, Inc. - PE Ratio

The PE Ratio as of June 2026 (TTM) for CytomX Therapeutics, Inc. (CTMX) is -5.67

According to CytomX Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.67. This represents a change of -95.46% compared to the average of -124.95 of the last 4 quarters.

CytomX Therapeutics, Inc. (CTMX) Historical PE Ratio (quarterly & annually)

How has CTMX PE Ratio performed in the past?

The mean historical PE Ratio of CytomX Therapeutics, Inc. over the last ten years is -27.68. The current -5.67 PE Ratio has changed 1.95% with respect to the historical average. Over the past ten years (40 quarters), CTMX's PE Ratio was at its highest in in the December 2017 quarter at 327.80. The PE Ratio was at its lowest in in the June 2025 quarter at -472.92.

CytomX Therapeutics, Inc. (CTMX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of CytomX Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CytomX Therapeutics, Inc. (CTMX) Average PE Ratio

How has CTMX PE Ratio performed in the past?

The current PE Ratio of CytomX Therapeutics, Inc. (CTMX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

CytomX Therapeutics, Inc. (CTMX) PE Ratio vs. Peers

How is CTMX’s PE Ratio compared to its peers?

CytomX Therapeutics, Inc.’s PE Ratio is greater than Erasca, Inc. (-14.70), less than Iovance Biotherapeutics, Inc. (-4.25), greater than MBX Biosciences, Inc. Common Stock (-19.56), greater than ArriVent BioPharma, Inc. Common Stock (-8.99), greater than MeiraGTx Holdings plc (-7.65), greater than Astria Therapeutics, Inc. (-5.88), less than MoonLake Immunotherapeutics (-4.95), less than Replimune Group, Inc. (-2.85), less than Ginkgo Bioworks Holdings, Inc. (-1.71), greater than Anavex Life Sciences Corp. (-5.89),

Build a custom stock screener for CytomX Therapeutics, Inc. (CTMX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CytomX Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CytomX Therapeutics, Inc. (CTMX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CytomX Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.